Clorox reported a 5% decrease in net sales to $1.81 billion, impacted by lower volume from cyberattack-related distribution losses and unfavorable foreign exchange rates. However, adjusted EPS increased by 13% to $1.71, driven by pricing and cost savings. The company is on track to restore lost distribution by the end of Q4 and expects to exit fiscal year 2024 with strong fundamentals.
Returned to normalized service levels by the end of the third quarter, enabling merchandising and distribution restoration in the fourth quarter.
Achieved the sixth consecutive quarter of gross margin expansion, supported by pricing in International and cost savings.
Made continued progress in restoring market share, with nearly 90% of cyberattack-related share losses now recovered.
Completed the divestiture of the Argentina business to evolve its portfolio for more consistent, profitable growth.
The company continues to expect net sales to be down low single digits and organic sales are still expected to be up low single digits, but also at the low end of the range. Gross margin is now expected to be up about 275 basis points. Adjusted EPS is now expected to be between $5.80 and $5.95, or an increase of 14% to 17%.
Visualization of income flow from segment revenue to net income